Compare Dollar General Corp. (DG) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dollar General Corp. vs IDEXX Laboratories, Inc. — how do they compare? Dollar General Corp. trades at $120.2 (market cap $26.49B), while IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and Dollar General Corp. pays a 1.97% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| DG | IDXX | |
|---|---|---|
Market Cap | $26.49B | $46.22B |
Sector | Consumer Staples | Health |
52-Week High | $156.26 | $766.68 |
52-Week Low | $95.94 | $526.44 |
Enterprise Value | $40.93B | $47.12B |
Dividend Yield | 1.97% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dollar General (DG) trades at $119.65, down 2.24% amid broader market weakness. The stock shows strong fundamentals with a P/E of 16.98 and P/S of 0.62, trading below analyst consensus target of $128.45. Recent earnings beats and positive cash flow trends ($395M net in 2025) support the bullish case, though profit margins have compressed from 7.01% in 2022 to 2.77% in 2025. Technical indicators show mixed signals with bullish overall sentiment but bearish moving averages.
Outlook remains positive given 52% analyst buy ratings and projected earnings growth, but investors face margin pressure and competitive threats from Walmart and Amazon. The stock offers value characteristics with upside to price targets, though same-store sales growth and cost management will be critical for sustained performance.
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dollar General Corp.
A leading American discount retailer, Dollar General operates over 18,000 stores in 47 states, selling branded and private-label products across a wide variety of categories. In fiscal 2021, 77% of net sales came from consumables (including paper and cleaning products, packaged and perishable food, tobacco, and health and beauty items), 12% from seasonal merchandise (such as toys, greeting cards, decorations, and gardening supplies), 7% from home products (for example, kitchen supplies, small appliances, and cookware), and 4% from basic apparel. Stores average roughly 7,400 square feet, and about 75% of Dollar General locations are in towns of 20,000 or fewer people. The firm emphasizes value, with most of its items sold at everyday low prices of $5 or less.
Read more on DG →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
